accepted manuscript

More documents

Recommendations

Info

201-205. ACCEPTED MANUSCRIPT [171] K.F. Winklhofer, The parkin protein as a therapeutic target in Parkinson's disease, Expert Opin Ther Targets 11 (2007) 1543-1552. [172] E.K. Tan, K.Y. Puong, D.K. Chan, K. Yew, S. Fook-Chong, H. Shen, P.W. Ng, J. Woo, Y. Yuen, R. Pavanni, M.C. Wong, K. Puvan, Y. Zhao, Impaired transcriptional upregulation of Parkin promoter variant under oxidative stress and proteasomal inhibition: clinical association, Hum Genet 118 (2005) 484- 488. [173] Y. Imai, M. Soda, R. Takahashi, Parkin suppresses unfolded protein stress- induced cell death through its E3 ubiquitin-protein ligase activity, The Journal of biological chemistry 275 (2000) 35661-35664. [174] M.D. Ledesma, C. Galvan, B. Hellias, C. Dotti, P.H. Jensen, Astrocytic but not neuronal increased expression and redistribution of parkin during unfolded protein stress, Journal of neurochemistry 83 (2002) 1431-1440. [175] Y. Higashi, M. Asanuma, I. Miyazaki, N. Hattori, Y. Mizuno, N. Ogawa, Parkin attenuates manganese-induced dopaminergic cell death, Journal of neurochemistry 89 (2004) 1490-1497. ACCEPTED MANUSCRIPT [176] K.F. Winklhofer, J. Tatzelt, C. Haass, The two faces of protein misfolding: gain- and loss-of-function in neurodegenerative diseases, The EMBO journal 27 (2008) 336-349. [177] M.J. LaVoie, G.P. Cortese, B.L. Ostaszewski, M.G. Schlossmacher, The effects of oxidative stress on parkin and other E3 ligases, Journal of neurochemistry 103 (2007) 2354-2368. [178] I.H. Henn, J.M. Gostner, J. Tatzelt, K.F. Winklhofer, Pathogenic mutations inactivate parkin by distinct mechanisms, Journal of neurochemistry 92 (2005) 63
114-122. ACCEPTED MANUSCRIPT [179] J.S. Schlehe, A.K. Lutz, A. Pilsl, K. Lämmermann, K. Grgur, I.H. Henn, J. Tatzelt, K.F. Winklhofer, Aberrant folding of pathogenic parkin mutants: aggregation versus degradation, The Journal of biological chemistry 283 (2008) 13771-13779. [180] K.F. Winklhofer, I.H. Henn, P. Kay-Jackson, U. Heller, J. Tatzelt, Inactivation of parkin by oxidative stress and C-terminal truncations; a protective role of molecular chaperones, The Journal of biological chemistry 278 (2003) 47199- 47208. [181] M.R. Cookson, P.J. Lockhart, C. McLendon, C. O'Farrell, M. Schlossmacher, M.J. Farrer, RING finger 1 mutations in Parkin produce altered localization of the protein, Human molecular genetics 12 (2003) 2957-2965. Epub 2003 Sep 2930. [182] W.J. Gu, O. Corti, F. Araujo, C. Hampe, S. Jacquier, C.B. Lucking, N. Abbas, C. Duyckaerts, T. Rooney, L. Pradier, M. Ruberg, A. Brice, The C289G and C418R missense mutations cause rapid sequestration of human Parkin into insoluble aggregates, Neurobiology of disease 14 (2003) 357-364. ACCEPTED MANUSCRIPT [183] E. Kyratzi, M. Pavlaki, D. Kontostavlaki, H.J. Rideout, L. Stefanis, Differential effects of Parkin and its mutants on protein aggregation, the ubiquitin-proteasome system, and neuronal cell death in human neuroblastoma cells, Journal of neurochemistry 102 (2007) 1292-1303. [184] S.R. Sriram, X. Li, H.S. Ko, K.K. Chung, E. Wong, K.L. Lim, V.L. Dawson, T.M. Dawson, Familial-associated mutations differentially disrupt the solubility, localization, binding and ubiquitination properties of parkin, Human molecular genetics 14 (2005) 2571-2586. 64
Page 1 and 2:
ÔØ ÅÒÙ× ÖÔØ Mitochondrial
Page 3 and 4:
Abstract ACCEPTED MANUSCRIPT Mitoch
Page 5 and 6:
ACCEPTED MANUSCRIPT function mechan
Page 7 and 8:
ACCEPTED MANUSCRIPT high lipophilic
Page 9 and 10:
ACCEPTED MANUSCRIPT transfer from N
Page 11 and 12:
ACCEPTED MANUSCRIPT force (ΔpH and
Page 13 and 14: ACCEPTED MANUSCRIPT about 1500 diff
Page 15 and 16: ACCEPTED MANUSCRIPT mtDNA point mut
Page 17 and 18: ACCEPTED MANUSCRIPT increases the v
Page 19 and 20: 2.1.2. PINK1 substrates ACCEPTED MA
Page 21 and 22: 2.2. Parkin ACCEPTED MANUSCRIPT 2.2
Page 23 and 24: ACCEPTED MANUSCRIPT Remarkably, LaV
Page 25 and 26: ACCEPTED MANUSCRIPT [204]. None of
Page 27 and 28: ACCEPTED MANUSCRIPT 218] (see Fig.
Page 29 and 30: ACCEPTED MANUSCRIPT strategies migh
Page 31 and 32: ACCEPTED MANUSCRIPT autophagy in PI
Page 33 and 34: 2.3. DJ-1 ACCEPTED MANUSCRIPT Mutat
Page 35 and 36: ACCEPTED MANUSCRIPT Similarly to ot
Page 37 and 38: ACCEPTED MANUSCRIPT 2527 amino acid
Page 39 and 40: Acknowledgements ACCEPTED MANUSCRIP
Page 41 and 42: References ACCEPTED MANUSCRIPT [1]
Page 43 and 44: ACCEPTED MANUSCRIPT Sciences of the
Page 45 and 46: ACCEPTED MANUSCRIPT biological chem
Page 47 and 48: ACCEPTED MANUSCRIPT [47] B. Janetzk
Page 49 and 50: 486-517. ACCEPTED MANUSCRIPT [63] B
Page 51 and 52: ACCEPTED MANUSCRIPT Parkinson's dis
Page 53 and 54: ACCEPTED MANUSCRIPT variants in idi
Page 55 and 56: ACCEPTED MANUSCRIPT causes of Parki
Page 57 and 58: ACCEPTED MANUSCRIPT [125] A. Grunew
Page 59 and 60: ACCEPTED MANUSCRIPT [136] G.B. John
Page 61 and 62: ACCEPTED MANUSCRIPT maturation or s
Page 63: ACCEPTED MANUSCRIPT [163] C. Hampe,
Page 67 and 68: ACCEPTED MANUSCRIPT (2004) 1328-133
Page 69 and 70: ACCEPTED MANUSCRIPT Dalkara, N. Oze
Page 71 and 72: ACCEPTED MANUSCRIPT [217] H. Deng,
Page 73 and 74: ACCEPTED MANUSCRIPT dispensable for
Page 75 and 76: 35 (2001) 301-310. ACCEPTED MANUSCR
Page 77 and 78: ACCEPTED MANUSCRIPT multiplications
Page 79 and 80: ACCEPTED MANUSCRIPT [270] A.M. Cuer
Page 81 and 82: ACCEPTED MANUSCRIPT Neuroscience le
Page 83 and 84: ACCEPTED MANUSCRIPT Ferrante, N.W.
Page 85 and 86: ACCEPTED MANUSCRIPT Meitinger, W. K
Page 87 and 88: ACCEPTED MANUSCRIPT ACCEPTED MANUSC
Page 89: ACCEPTED MANUSCRIPT ACCEPTED MANUSC
show all

accepted manuscript

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?